OSTROWSKI, JACEK,GARCIA, RICARDO,WURTZ, NICHOLAS R.
申请号：
CA3006291
公开号：
CA3006291A1
申请日:
2016.11.21
申请国别(地区):
CA
年份:
2017
代理人:
摘要：
The disclosure generally relates to a therapeutic approach based on the stimulation of resolution of inflammation by the Formyl-Peptide Receptor 2/Lipoxin A4 receptor (FPR2/ALX) for the treatment of heart disease.
